HBV相关肝衰竭抗病毒治疗进展

何卫平; 王慧芬

HBV相关肝衰竭抗病毒治疗进展

基金项目:

军队“十一五”中医药研发推广专项重大临床攻关课题(2006231001)；北京市首发基金重点课题(公示中)；

详细信息

中图分类号: R512.6;R575.3
计量
- 文章访问数: 3230
- HTML全文浏览量: 5
- PDF下载量: 862
- 被引次数: 0
出版历程
- 出版日期: 2009-03-20

Research funding:

摘要

HTML全文

参考文献(15)

[1]Yuan HJ, Yuen MF, Ka-Ho Wong D, et al.The relationship be-tween HBV-DNA levels and cirrhosis-related complications inChinese with chronic hepatitis B[J].J Viral Hepat, 2005, 12 (4) ∶373-379.

[2]Van Zonneveld M, Honkoop P, Hansen BE, et al.Long-term fol-low-up of alpha-interferon treatment of patients with chornic hepa-titis B[J].Hepatology, 2004, 39 (3) ∶804-810.

[3]Liaw YF, Sung JJ, Chow WC, et al.Lamivudine for patients withchronic hepatitis B and advanced liver disease[J].N Engl J Med, 2004, 351 (15) ∶1521-1531.

[4]Di Marco V, Di Stefano R, Ferraro D, et al.HBV-DNA suppres-sion and disease course in HBVcirrhosis patients on long-tern lami-vudine therapy[J].Antivir Ther, 2005, 10 (3) ∶431-439.

[5]Tseng PL, Lu SN, Tung HD, et al.Determinants of early mortalityand benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis[J].J Viral Hepat, 2005, 12 (4) ∶386-392.

[6]Su GG, Zhao NF, Zhou Y, et al.Adefovir dipivoxil in treatment ofdecompensated liver cirrhosis patients with YMDD mutation[J].Zhe-jiang Da Xue Xue Bao Yi Xue Ban, 2005, 34 (5) ∶470-472.

[7]Price JS, France AJ, Moaven LD, et al.Foscarnet in fulminant hep-atitis B[J].Lancet.1986, 2 (8518) ∶1273.

[8]孙燕, 关琦, 李广明, 等.膦甲酸钠治疗重型乙型肝炎临床研究[J].医药论坛杂志, 2006, 27 (3) ∶64-65.

[9]Tillmann HL, Hadem J, Leifeld L, et al.Safety and efficacy of lami-vudine in patients with severe acute or fulminant hepatitis B, a multi-center experience[J].J Viral Hepat, 2006, 13 (4) ∶256-263.

[10]Chien RN, Lin CH, Liaw YF.The effect of lamivudine therapy inhepatic decompensation during acute exacerbation of chronic hepatitisB[J].J Hepatol, 2003, 38 (3) ∶322-327.

[11]Tsang SW, Chan HL, Leung NW, et al.Lamivudine treatment forfulminant hepatic failure due to acute exacerbation of chronic hepati-tis B infection[J].Aliment Pharmacol Ther, 2001, 15 (11) ∶1737-1744.

[12]Yuen MF, Sablon E, Hui CK, et al.Prognostic factors in severeexacerbation of chronic hepatitis B[J].CID, 2003, 36 (8) ∶978-984.

[13]Tsubota A, Arase Y, Suzuki Y, et al.Lamivudine monotherapy forspontaneous severe acute exacerbation of chronic hepatitis B[J].JGastroenterol Hepatol, 2005, 20 (3) ∶426-432.

[14]Lo CM, Liu CL, Lau GK, et al.Liver transplantation for chronichepatitis B with lamivudine-resistant YMDD mutant using add-onadefovir dipivoxil plus lamivudine[J].Liver Transpl, 2005, 11 (7) ∶807-813.

[15]张南, 夏杰, 邓国宏, 等.拉米夫定对慢性重型乙型肝炎患者生存率的提高[J].第三军医大学学报, 2008, 30 (1) ∶75-77.

施引文献

资源附件(0)

访问统计